Skip to content

Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.

Investigation of the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) on appetite and on fasting and postprandial levels of insulin, glucose, leptin and ghrelin in healthy adult volunteers.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12607000138482
Acronym
Stimulant Growth Study: pilot study - adults
Enrollment
12
Registered
2007-02-21
Start date
2007-01-15
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Stimulant medication can be associated with slowing of growth in children with attention deficit hyperactivity disorder (ADHD), possibly by appetite suppression mediated by hormones such as leptin and ghrelin. Twelve healthy adult volunteers will have fasting blood tests for leptin, ghrelin, insulin and glucose, with these tests repeated after a meal. This will be done twice, once on medication (dexamphetamine or methylphenidate) and once on placebo. The effect of medication on food intake and alertness will be tested, together with subjects’ assessments of appetite and medication side effects.

Interventions

Double blind randomised placebo controlled trial investigating the effect of a single dose of stimulant medication (dexamphetamine 10mg or methylphenidate 20mg) given orally to fasted healthy adult volunteers. Each subject tested with medication and placebo (calcium carbonate) to serve as their own control. Minimum wash out period 4 days.

Sponsors

Chief investigator Dr Alison Poulton
Lead SponsorIndividual

Study design

Allocation
Randomised controlled trial
Intervention model
Crossover
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
17 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

Fit and healthy

Exclusion criteria

Current treament of medical condition, previous regular use of stimulant medication, history of substance abuse, BMI>30.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026